These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 10918587)

  • 21. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
    Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
    Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.
    Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H
    Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain.
    Foehr ED; Raffioni S; Murray-Rust J; Bradshaw RA
    J Biol Chem; 2001 Oct; 276(40):37529-36. PubMed ID: 11459840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
    Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
    Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived phosphopeptide.
    Dunican DJ; Williams EJ; Howell FV; Doherty P
    Cell Growth Differ; 2001 May; 12(5):255-64. PubMed ID: 11373272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of FGF receptors by mutations in the transmembrane domain.
    Li Y; Mangasarian K; Mansukhani A; Basilico C
    Oncogene; 1997 Mar; 14(12):1397-406. PubMed ID: 9136983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells.
    Tenev T; Böhmer SA; Kaufmann R; Frese S; Bittorf T; Beckers T; Böhmer FD
    Eur J Cell Biol; 2000 Apr; 79(4):261-71. PubMed ID: 10826494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.
    Lorenzi MV; Castagnino P; Chen Q; Chedid M; Miki T
    Oncogene; 1997 Aug; 15(7):817-26. PubMed ID: 9266968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis.
    Jang JH
    Oncogene; 2005 Jan; 24(5):945-8. PubMed ID: 15558020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology.
    Shimizu A; Takashima Y; Kurokawa-Seo M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):113-20. PubMed ID: 11779141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta PDGF receptor mutants defective for mitogenesis promote neurite outgrowth in PC12 cells.
    Vetter ML; Bishop JM
    Curr Biol; 1995 Feb; 5(2):168-78. PubMed ID: 7743180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors.
    Wang JK; Goldfarb M
    Oncogene; 1997 Apr; 14(15):1767-78. PubMed ID: 9150382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor receptors display both common and distinct signaling pathways.
    Shaoul E; Reich-Slotky R; Berman B; Ron D
    Oncogene; 1995 Apr; 10(8):1553-61. PubMed ID: 7731710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.
    Chen J; Williams IR; Lee BH; Duclos N; Huntly BJ; Donoghue DJ; Gilliland DG
    Blood; 2005 Jul; 106(1):328-37. PubMed ID: 15784730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3.
    Agazie YM; Movilla N; Ischenko I; Hayman MJ
    Oncogene; 2003 Oct; 22(44):6909-18. PubMed ID: 14534538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
    Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
    Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.